No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Jefferies Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $18
Morgan Stanley Upgrades PTC, Cuts Immuneering, Amicus
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
Amicus Therapeutics (FOLD) Is a Top-Ranked Momentum Stock: Should You Buy?
Amicus Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley
Morgan Stanley Downgrades Amicus Therapeutics(FOLD.US) to Hold Rating, Cuts Target Price to $12